Home / Publications / EPO's strict approach to deciding if a composition...

EPO's strict approach to deciding if a composition can benefit from medical use protection - EPO Technical Board of Appeal decision; T 2136/15

30 May 19

The EPO Technical Board of Appeal (TBA) reviewed the law around novelty of use, and determined that in the case of CardioPolymer, Inc.'s European patent application (EP07837908.8), the claimed chemical entity did not qualify as a 'substance or composition'...

Read more

Authors

Jane Hollywood
Jane Hollywood
Senior Associate
London
Frances Denney
Frances Denney
Associate European Patent Attorney
London